Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
US Patent 11590123 Ophthalmic compositions
Overview
Structured Data
Issues
Contributors
Activity
Access by API
Access by API
Is a
Patent
Current Assignee
Aerie Pharmaceuticals
Date Filed
July 6, 2022
Date of Patent
February 28, 2023
Patent Applicant
Aerie Pharmaceuticals
Patent Application Number
17858889
Patent Citations
US Patent 10568878 Combination therapy
US Patent 10588901 Combination therapy
US Patent 10654844 Dual mechanism inhibitors for the treatment of disease
US Patent 10858339 Aryl cyclopropyl-amino-isoquinolinyl amide compounds
US Patent 10882840 Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds
US Patent 10899714 6-aminoisoquinoline compounds
US Patent 11020385 Combination therapy
US Patent 11021456 Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds
US Patent 11028081 Dual mechanism inhibitors for the treatment of disease
US Patent 11185538 Compositions for treating glaucoma or reducing intraocular pressure
•••
Patent Jurisdiction
United States Patent and Trademark Office
Patent Number
11590123
Patent Primary Examiner
Yevgeny Valenrod
CPC Code
A61K 9/08
A61K 31/5575
A61K 45/06
A61K 31/472
A61K 47/186
A61K 47/26
A61K 47/02
A61K 9/0048
Find more entities like US Patent 11590123 Ophthalmic compositions
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
SUBSCRIBE